Literature DB >> 18614844

A new murine model of allergic rhinitis by repeated intranasal Cry j 1 challenge.

Masako Tsunematsu1, Taketo Yamaji, Daisuke Kozutsumi, Rika Murakami, Hiroichi Nagai, Kohsuke Kino.   

Abstract

To evaluate the long-lasting effects of new therapeutic approaches to allergies, we established a new model of allergic rhinitis by repeated challenges with intranasal Cry j 1, a common Japanese cedar (Cryptomeria japonica) pollen allergen, in B10.S mice. We sensitized B10.S mice subcutaneously with Cry j 1/alum three times at 1-week intervals. Five weeks after the final sensitization, we challenged the mice by instilling Cry j 1 intranasally for 5 consecutive days starting 1 day after intranasal histamine pretreatment (challenge-1). We challenged the mice by instilling histamine and Cry j 1 intranasally again 12 weeks later (challenge-2). There were significantly more sneezes after challenge-2 than challenge-1. Cry j 1-specific IgE levels in serum were significantly increased in both challenge-1 and 2 after continuous nasal antigen challenge. Serum levels of anti-Cry j 1 IgE in challenge-2 was 2.3 times higher than after challenge-1. Thus, we have established a new model of seasonal allergic rhinitis in B10.S mice by repeated intranasal antigen challenge, and this model may help elucidate mechanisms of allergic rhinitis and the development of new drugs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18614844     DOI: 10.2220/biomedres.29.119

Source DB:  PubMed          Journal:  Biomed Res        ISSN: 0388-6107            Impact factor:   1.203


  3 in total

1.  Establishment of a new animal model of allergic rhinitis with biphasic sneezing by intranasal sensitization with Staphylococcal enterotoxin B.

Authors:  Rong Sun; Xinye Tang; Hongbing Yao; Suling Hong; Yang Yang; Wei Kou; Ping Wei
Journal:  Exp Ther Med       Date:  2015-05-21       Impact factor: 2.447

2.  Transcutaneous Peptide Immunotherapy of Japanese Cedar Pollinosis Using Solid-in-Oil Nanodispersion Technology.

Authors:  Momoko Kitaoka; Yoko Shin; Noriho Kamiya; Yoshinori Kawabe; Masamichi Kamihira; Masahiro Goto
Journal:  AAPS PharmSciTech       Date:  2015-05-19       Impact factor: 3.246

3.  Oral immunotherapy for pollen allergy using T-cell epitope-containing egg white derived from genetically manipulated chickens.

Authors:  Yoshinori Kawabe; Yuuki Hayashida; Kensaku Numata; Shota Harada; Yoshifumi Hayashida; Akira Ito; Masamichi Kamihira
Journal:  PLoS One       Date:  2012-10-29       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.